Skip to main navigation
News
Investors
Careers
Contact
About Us
Our Mission & Vision
The Zevra Story
Leadership
Board of Directors
Our Approach
What We Do
Partnering
Patients & Providers
Niemann-Pick Disease Type C
Sleep Disorders
Expanded Access Policy
Products
MIPLYFFA™
Olpruva®
Azstarys®
Science & Pipeline
Pipeline
Clinical Trials
Publications & Presentations
Investors
Investor Relations
Events & Presentations
Stock Information
Press Releases
Corporate Governance
SEC Filings
Contact
Email Alerts
Careers
Culture
Job Openings
Contact
info@zevra.com
888.958.1253
Facebook
Twitter
LinkedIn
Home
Menu
Menu
Event Details
Overview
Events & Presentations
Stock Information
Stock Quote & Chart
Historic Stock Lookup
Analyst Coverage
Press Releases
Corporate Governance
Leadership
Board of Directors
Committee Composition
IRS – Required Disclosures
State Compliance
SEC Filings
Quarterly Results
Contact
Email Alerts
FAQs
Zevra Therapeutics Q1 2024 Earnings Call
05-08-2024 8:00 AM EDT
Listen to webcast
Scroll to top